Important note: Information in this article was accurate in August 2004. The state of the art may have changed since the publication date.
 |
HIV Treatment Bulletin - Vol. 5, No. 7, August/September 2004
The biennial World AIDS Conference, which alternates hosting by countries in the Northern and Southern hemispheres, is the largest and broadest focused of the international HIV meetings. At this year’s event close to 20,000 delegates met at a conference centre on the outskirts of Bangkok. Although basic and clinical science tracks are still important, they are now outnumbered by combined studies on social, prevention, community and access.
The meeting rightly continues to be a focus for access to treatment on a global scale, following advances made at the meeting in Durban in 2000, and in Barcelona two years ago which led to the launch of the 3x5 treatment initiative to treat three million people by 2005.
With only 440,000 people on treatment in July, the shortfall has been highlighted in previous issues of HTB, and is covered in detail in the access overview from the conference (below).
This meeting also saw IV drug user (IVDU) issues included as a priority on the agenda for access to treatment. Some of the largest recent epidemics have been mainly driven by this route of infection. Prevention and harm reduction programmes are often poorly funded, even if there is political will to support them. More often, as with treatment itself, this is very limited where it exists at all.
We include several important reports on this issue at the start of our coverage.
Unless stated otherwise, all references in the following conference reports are to the programme and abstracts of the XV International AIDS Conference, July 11-16, 2004, Bangkok, Thailand.
Searchable abstracts from the meeting are already online:
Many of the lectures are available online, as are some slide sets for the webcast. Transcripts of some lectures are also available as pdf files,
http://www.kaisernetwork.org/aids2004
This meeting did not include a large amount of new clinical data – and there seems to be a consensus from both clinicians and advocates who attended the meeting. The most important studies are included here, but several good websites also cover other studies and presentations.
Specific reports are linked in the On The Web section of this issue of HTB, and particularly useful sites include:
http://www.hivandhepatitis.com
Public statements, transcriptions, reports and pictures relating to community and activist demonstrations are online at:
http://www.actupny.org/reports/Bangkok/
We will also include additional reports in the next issue of HTB (October/November 2004).
040810
IB040507-02
©2004. I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7407 8488 F: +44 (0) 20 7407 8489
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
